The duties imposed on compensation committees of publicly traded companies have evolved and grown over time. This seventh edition of the Compensation Committee Handbook from the lawyers of the Executive Compensation and...more
On October 30, 2019, the Delaware Court of Chancery struck a major blow against the plaintiffs’ bar’s efforts to lower the statutory hurdle to maintaining stockholder derivative claims. A stockholder of Ultragenyx...more
11/4/2019
/ Board of Directors ,
Business Judgment Rule ,
Compensation & Benefits ,
Controlling Stockholders ,
Corporate Counsel ,
Delaware General Corporation Law ,
Derivative Suit ,
Dismissals ,
Executive Compensation ,
Pharmaceutical Industry ,
Pre-Suit Notice ,
Shareholder Demands